Ono Pharmaceutical Co., Ltd. announced that the Company decided the following changes of Members of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at its Board of Directors Meeting held April 05, 2021. New candidate of Members of the Board of Directors, Kiyoaki Idemitsu - Corporate Executive Officer, Executive Director, Clinical Development. Resigning Members of the Board of Directors: Hiroshi Awata - Vice President, Executive Officer, Tokyo Branch Head. After resigning, he will be appointed as a senior partner; Jun Kurihara - Outside Members of the Board of Director. Audit & Supervisory Board Members (as of mid of June 2021): New candidate of Outside Audit & Supervisory Board Member (current post in the bracket) - Hironobu Tanisaka (full-time) (Currently: Director, Business Audit Department). Resigning outside Audit & Supervisory Board Members (voluntarily): Shinji Fujiyoshi (full-time) (Currently: Audit & Supervisory Board Member). After resigning, he will be appointed as a part-time adviser. New candidates of Corporate Officer: Masaki Ito - Director, Corporate Planning Department. Resigning Corporate Officers: Katsunori Morio - Corporate Officer, Division Director, Sales Division, Metropolitan Region. After resigning, he will be appointed as a full-time adviser; Takuya Seko - Officer, Chief Officer, Quality Assurance Management. After resigning, he will be appointed as an Officer.